ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintSite TitleTitle ChevronIcon Twitter
Health Technology

Santen Pharmaceutical Co., Ltd.

Business Summary

Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the Pharmaceuticals and Other segments. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. The Other segment offers medical equipment and devices. The company was founded by Kenkichi Tagushi in 1890 and is headquartered in Osaka, Japan.

Financial Highlights

Mar 2019 JPYUSD
Revenue234,026M2,110.34M
Gross Profit134,165M1,209.84M
Operating income41,242M371.90M
Income before tax43,117M388.81M
Net income31,953M288.13M
EBITDA52,211M470.81M
Diluted EPS78.430.70
Dividends Per Share260.23
Total Assets391,186M3,534.22M
Total liabilities98,614M890.94M
Total equity290,900M2,628.17M
Operating cash flow32,894M296.62M
Currency in JPYCurrency in USD

Historical Data

 Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Revenue 161,831M 195,291M 199,096M 224,942M 234,026M
Gross Profit 100,660M 115,233M 115,763M 129,618M 134,165M
Operating income 34,995M 36,502M 33,301M 38,637M 41,242M
Income before tax 35,863M 79,470M 30,055M 39,261M 43,117M
Net income 24,032M 53,373M 21,717M 35,247M 31,953M
EBITDA 41,953M 45,840M 43,183M 49,533M 52,211M
Diluted EPS 57.93 128.41 52.76 86.42 78.43
Dividends Per Share 22 25 26 26 26
Total Assets 304,200M 355,399M 358,906M 388,463M 391,186M
Total liabilities 92,421M 95,390M 102,977M 100,904M 98,614M
Total equity 211,779M 260,009M 255,110M 285,823M 290,900M
Operating cash flow 25,386M 22,525M 10,843M 42,843M 32,894M
 Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Revenue 1,473.11M 1,626.28M 1,838.58M 2,029.56M 2,110.34M
Gross Profit 916.28M 959.60M 1,069.03M 1,169.49M 1,209.84M
Operating income 318.55M 303.96M 307.52M 348.60M 371.90M
Income before tax 326.45M 661.78M 277.54M 354.23M 388.81M
Net income 218.75M 444.46M 200.54M 318.02M 288.13M
EBITDA 381.88M 381.73M 398.78M 446.91M 470.81M
Diluted EPS 0.52 1.06 0.48 0.77 0.70
Dividends Per Share 0.20 0.20 0.24 0.23 0.23
Total Assets 2,536.58M 3,162.05M 3,220.90M 3,652.68M 3,534.22M
Total liabilities 770.65M 848.70M 924.14M 948.79M 890.94M
Total equity 1,765.92M 2,313.35M 2,289.41M 2,687.56M 2,628.17M
Operating cash flow 231.08M 187.57M 100.13M 386.55M 296.62M

Valuation Measures

Mar 2019
PER20.96
ROA8.19%
ROE11.08%
Operating margin17.62%
Profit margin13.65%

Key executives

  • Chairman & Chief Executive Officer: Akira Kurokawa
  • President, COO & Representative Director: Shigeo Taniuchi
  • CFO, General Manager-Finance & Administration: Kazuo Koshiji
  • Chief Information Officer & Executive Officer: Noriaki Yamamoto
  • Chief Scientific Officer, General Manager-R&D: Naveed K. Shams

Shareholders

  • MFS International (UK) Ltd. (5.3%)
  • Black Creek Investment Management, Inc. (5.0%)
  • Massachusetts Financial Services Co. (4.2%)
  • Mitsubishi UFJ Financial Group, Inc. (3.4%)
  • Sumitomo Mitsui Trust Asset Management Co., Ltd. (3.2%)
  • Nippon Life Insurance Co. (2.6%)
  • Nomura Asset Management Co., Ltd. (2.5%)
  • The Vanguard Group, Inc. (2.5%)
  • Ono Pharmaceutical Co., Ltd. (2.3%)
  • Nikko Asset Management Co., Ltd. (2.0%)

Contact Details

  • Website:http://www.santen.co.jp
  • Address: Grand Front Osaka Tower A, 25/F, 4-20 Ofuka-cho, Osaka, 530-8552, Japan
  • Phone: +81.6.6321.7000

Related Companies

  • Santen Pharmaceutical Restricted Stock Compensation Plan
  • Santen Philippines, Inc.
  • Santen Pharma Malaysia Sdn. Bhd.
  • Santen Thailand Co. Ltd.
  • Santen SA
  • Santen Eye Care Co., Ltd.
  • Santen Business Services Co., Ltd.
  • Claire Co., Ltd.
  • Santen Italy SRL
  • Santen Pharmaceutical Spain SL
  • SantenPharma AB
  • Santen India Pvt Ltd.
  • Santen Pharmaceutical Korea Co., Ltd.
  • Santen Pharmaceutical Asia Pte Ltd.
  • Santen Pharmaceutical Sales & Marketing (Suzhou) Co., Ltd.
  • Taiwan Santen Pharmaceutical Co., Ltd.
  • Santen SAS
  • Santen Pharmaceutical Trust
  • Santen Pharmaceutical (China) Co., Ltd.
  • Santen Holdings U.S., Inc.
  • Santen Pharmaceutical Pension Fund
  • Santen GmbH
  • Santen Oy
  • Santen Holdings EU BV
  • InnFocus, Inc.
  • Santen, Inc.
  • Star Ab Oy
  • Advanced Vision Science, Inc.

Competitors

  • Nicox SA
  • EyePoint Pharmaceuticals, Inc.
  • Healios KK
  • G-treeBNT Co., Ltd.
Last Updated on 1 Apr, 2020

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Get Unlimited access

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends April 30th

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media